David McArthur
Corporate Officer/Principal chez 3 SIXTY RISK SOLUTIONS LTD.
Profil
David McArthur is currently a Director at African Cannabis Corp., Chief of Staff at Canada Department of Natural Resources, and Chief Corporate Affairs Officer at 3 Sixty Risk Solutions Ltd.
He previously worked as Chief of Staff at Indigenous & Northern Affairs Canada and Department of Canadian Heritage.
Postes actifs de David McArthur
| Sociétés | Poste | Début |
|---|---|---|
| 3 SIXTY RISK SOLUTIONS LTD. | Corporate Officer/Principal | - |
| Canada Department of Natural Resources | Responsable des Ressources Humaines | - |
African Cannabis Corp.
 African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de David McArthur
| Sociétés | Poste | Fin |
|---|---|---|
| Indigenous & Northern Affairs Canada | Responsable des Ressources Humaines | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 3 SIXTY RISK SOLUTIONS LTD. | Finance |
| Entreprise privées | 3 |
|---|---|
| Canada Department of Natural Resources | Government |
| Indigenous & Northern Affairs Canada | |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Health Services |
